‘Solving All Disease’ Using AI is the Mission of Alphabet's Isomorphic Labs – Its $600M in Funding Will Help

‘Solving All Disease’ Using AI is the Mission of Alphabet's Isomorphic Labs – Its $600M in Funding Will Help

AI drug design and development company Isomorphic Labs announced on Monday that it raised $600 million in its first external funding round. Thrive Capital led the financing round with participation from Google’s GV, and follow-on capital from Alphabet, its parent company and an existing investor. Isomorphic Labs described plans to use the funds to drive biomedical advances through its AI drug design engine. The company is also enhancing its drug…